However, in another study of pneumococcal superinfection following influenza infection in mice, treatment with exogenous IL-22 enhanced the lung barrier and reduced bacterial transmission but did not affect the bacterial burden (Barthelemy et al., 2018). The gene discussed is IL22; the disease is influenza.